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Abstract
Background
Clinical manifestations and outcomes of atherosclerotic disease differ between ethnic
groups. In addition, the prevalence of risk factors is substantially different. Primary preven-
tion programs are based on data derived from almost exclusively White people. We investi-
gated how race/ethnic differences modify the associations of established risk factors with
atherosclerosis and cardiovascular events.
Methods
We used data from an ongoing individual participant meta-analysis involving 17 population-
based cohorts worldwide. We selected 60,211 participants without cardiovascular disease
at baseline with available data on ethnicity (White, Black, Asian or Hispanic). We generated
a multivariable linear regression model containing risk factors and ethnicity predicting mean
common carotid intima-media thickness (CIMT) and a multivariable Cox regression model
predicting myocardial infarction or stroke. For each risk factor we assessed how the associ-
ation with the preclinical and clinical measures of cardiovascular atherosclerotic disease
was affected by ethnicity.
Results
Ethnicity appeared to significantly modify the associations between risk factors and CIMT
and cardiovascular events. The association between age and CIMT was weaker in Blacks
and Hispanics. Systolic blood pressure associated more strongly with CIMT in Asians. HDL
cholesterol and smoking associated less with CIMT in Blacks. Furthermore, the association
of age and total cholesterol levels with the occurrence of cardiovascular events differed
between Blacks and Whites.
Conclusion
The magnitude of associations between risk factors and the presence of atherosclerotic dis-
ease differs between race/ethnic groups. These subtle, yet significant differences provide
insight in the etiology of cardiovascular disease among race/ethnic groups. These insights
aid the race/ethnic-specific implementation of primary prevention.
Introduction
Cardiovascular disease (CVD) has historically been considered a disease of the developed
world.[1] However, CVD is rapidly becoming the largest contributor to morbidity and mortal-
ity in growing economies with diverse race/ethnic groups.[2] Furthermore, due to globally
increasing mobility large race/ethnic minority groups arise in developed countries. As primary
prevention of CVD is key, adequate risk prediction models are necessary to identify and treat
high-risk individuals.
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To date, most research on primary prevention and risk scores of CVD has been conducted
amongst Whites. For example, the landmark Framingham Risk Score (FRS)[3] and the Euro-
pean SCORE[4] have been developed in a largely White population.
Despite recalibrating risk scores for specific race/ethnic groups, it has been shown that exist-
ing scores—even scores with ethnicity as a covariate—perform inconsistently among different
race/ethnic groups. This results in both under- and overestimating risk, seriously compromis-
ing their usefulness in diverse race/ethnic groups.[5] Both QRISK2 and the FRS, identified only
10% to 24% of individuals to be at high risk of those who experienced cardiovascular (CV)
events among African Caribbeans. One study recalibrated the FRS and additionally studied the
value of the risk factors individually for Whites, Blacks and Mexican Americans; revealing dif-
ferences in risk factor association with cardiovascular disease.[6] For example, for CVDmor-
tality the hazard ratio (HR) of age was significantly higher in Whites as compared to Blacks
and Mexican Americans. Also, the HR for high-density lipoprotein (HDL) cholesterol was sig-
nificantly higher in Mexican Americans when compared to Whites.
The prevalence of several established cardiovascular risk factors (systolic blood pressure,
use of antihypertensive drugs, diabetes, smoking, total cholesterol and HDL-cholesterol)[7]
also differs between race/ethnic groups.[8] For example, diabetes is more prevalent in Blacks
and Hispanics than in Asians andWhites.[9] But whether differences in absolute risk factor
levels also entail race/ethnic differences in the associations with atherosclerosis and CVD has
not yet been clarified. This gap in our knowledge has very recently been underlined by the
American Heart Association guidelines on the assessment of cardiovascular risk.[10] They
strongly recommend “continued research to fill gaps in knowledge regarding short- and long-
term atherosclerotic cardiovascular disease risk assessment and outcomes in all race/ethnic
groups (. . .) Further research should include analyses of short- and long-term risk in diverse
groups”.
In order to fill this knowledge gap, a large multi-ethnic cohort with a sufficient number of
CV events is needed. For this purpose we used the individual participant data meta-analysis
USE-IMT cohort.[11] In addition to analyzing the associations with CV events, this cohort
also offers the opportunity to assess differences among race/ethnic groups in the association of
risk factors to subclinical atherosclerosis measured by mean common carotid intima media
thickness (CIMT).
Methods
Study population
USE-IMT is an ongoing individual participant data meta-analysis of which the methods have
been described in detail elsewhere.[11] In short, general population cohorts were identified
using literature search and expert suggestions. For inclusion in USE-IMT, cohorts were
required to have available baseline data on age, sex, blood pressure, cholesterol fractions, smok-
ing status, use of antihypertensive medication, diabetes mellitus and CIMT-measurements and
follow-up information on occurrence of cardiovascular events. For the current analysis, we
included the participating cohorts of which data on ethnicity on an individual level were avail-
able (n = 9). Cohorts that did not have information on ethnicity were included if it was reason-
able to assume that>95% of the participants belonged to one race/ethnic group due to either
selection of participants or race/ethnic homogeneity of the source population (n = 6). Ethnicity
was recoded when applicable, to create uniform race/ethnic groups for analysis. Details con-
cerning this recoding process and the original classification can be found in S1 Table. As our
research is focused on the first-time events in asymptomatics, only individuals to whom the
Framingham criteria [7] are applicable were included in the current analyses.
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Ethics statement
This study was approved by the institutional review committee of the University Medical Cen-
tre Utrecht. Each individual cohort obtained approval from a local Ethical Review Board and
written informed consent from all participants. All authors exchanged a material transfer
agreement. This study conforms to the declaration of Helsinki.
USE-IMT, CIMT and CV events
Out of the 17 cohorts participating in USE-IMT, we included 15 cohorts[12–26], consisting of
66,213 individuals. After excluding individuals of whom individual ethnicity was not known
(n = 285) or who had already experienced a cardiovascular event (n = 5,717) 60,211 individuals
were included for analyses. This group consisted of 46,788 Whites, 7,200 Blacks, 3,816 Asians
and 2,407 Hispanics.
Incomplete data on mean common CIMT, cardiovascular risk factors, and (time to) CV
events, approximately 12% of total values, were imputed, as described previously.[11] This
imputation was done to increase power and to reduce omitted variable bias.[27]
Average mean common CIMT was calculated for each individual using the maximum set of
carotid angles, near and/or far wall measurements, and left and/or right side measurements
that were assessed within each cohort. Time to first fatal or non-fatal myocardial infarction or
stroke (hemorrhagic or ischemic) was used as a primary endpoint in this analysis.
Statistical analysis
Baseline data are represented as means with standard deviations (SD) for continuous variables
and as percentages for categorical variables. We describe our population both by their original
cohort (Table 1) and by race/ethnic group (Table 2). All statistical analyses were performed in
R (version 2.15.1).
To examine the influence of ethnicity on associations of risk factors with mean common
CIMT and CV events, we used linear regression models and Cox regression models, respec-
tively. For both questions, we first fitted a model containing the Framingham risk factors (age,
sex, systolic blood pressure (SBP), HDL-cholesterol, total cholesterol, current smoking, pres-
ence of diabetes and antihypertensive drug use)[7] and ethnicity as independent variables.
Mean common CIMT (linear regression-log transformed) and a combined endpoint of first-
time stroke or myocardial infarction (Cox regression) were used as an outcome, respectively.
To take between-study-variation into account, we took a random effects approach for each
original cohort. We then extended this model by adding the interaction terms for ethnicity
with each risk factor. Whites were the reference group in all analyses.
We first compared the interaction model to the first model using a likelihood ratio test. Sub-
sequently, we tested the significance of the interaction terms. Finally, we calculated hazard
ratios and betas (with 95% confidence intervals) for each risk factor in each race/ethnic group,
and tested for significance of individual interaction terms using a Wald test. Due to the large
number of tests performed, we took a conservative threshold for interaction at pinteraction = 0.05
(commonly accepted p-values for interactions are 0.1 or 0.2). In these analyses, Whites were
the reference group. Interaction terms were only considered significant when significantly add-
ing to the model without interaction terms and when significantly different fromWhites.
No comparisons between ethnicities were performed, except for the comparisons to Whites.
A two-sided significance level of 0.05 was used.
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Results
TheWhite race/ethnic group was derived from 13 cohorts that originated from Canada, the
United States of America (USA) and Europe. The Black group was derived from 7 cohorts,
with the majority of individuals residing in the USA. The Asian group comprised of 8 cohorts.
The majority of Asians (63.5%) originated from Japan; another substantial part (21% of total)
of Asians was Chinese American. The Hispanics were derived from three (two American and
one Canadian) cohorts. The characteristics of each cohort are described in Table 1. The mean
age for the entire cohort was 59 years (SD 10), 51% were male. Median follow-up time was 9
Table 1. Details of participating USE-IMT cohorts.
Cohort Country Individuals
(n)
White
(n)
Black
(n)
Asian
(n)
Hispanic
(n)
Age
(years)
Gender
(% men)
Mean
CIMT
(mm,
sd)
FU
(years)
Stroke
(n)
MI
(n)
CV
event
(n)
ARIC[12] USA 14,728 10,750 3,978 - - 54.0 43.1 0.65
(0.15)
12.3 540 829 1,285
CAPS[13] Germany 4,798 4,798 - - - 49.4 48.1 0.72
(0.14)
8.0 91 68 153
CHS[14] USA 4,365 3,700 661 4 - 72.4 38.6 0.87
(0.16)
10.4 645 590 1,108
CIRCS[15] Japan 1,939 - - 1,939 - 65.5 75.7 - 7.9 89 23 109
EAS[16] UK 980 980 - - - 68.9 49.1 0.77
(0.28)
12.2 28 11 39
FATE[17] Canada 1,560 1,548 10 1 1 49.4 99.8 0.72
(0.18)
7.5 11 22 33
Hoorn[18] NLD 308 308 - - - 68.7 48.1 0.85
(0.15)
7.4 6 11 16
KHID[19] Finland 908 908 - - - 51.2 100.0 0.76
(0.16)
13.1 58 114 159
Malmö[20] Sweden 5,163 5,163 - - - 57.5 40.5 0.77
(0.15)
10.4 184 186 251
MESA[21] USA 6,814 2,622 1,893 803 1,496 62.2 47.2 0.76
(0.18)
6.0 116 140 355
NBS[22] NLD 1,172 1,160 9 3 - 60.8 46.7 0.83
(0.11)
3.8 3 13 16
NOMAS
[23]
USA 1,494 256 295 33 910 68.9 40.0 0.73
(0.09)
7.9 63 55 108
OSACA2
[24]
Japan 484 - - 484 - 65.5 49.6 0.87
(0.27)
4.4 22 2 24
Tromsø
[25]
Norway 5,699 5,699 - - - 59.3 47.2 0.78
(0.16)
10.1 352 534 830
Whitehall
[26]
UK 9,799 8,896 354 549 - 61.2 67.1 0.78
(0.15)
6.0 110 138 244
Combined 60,211 46,788 7,200 3,816 2,407 59.0 51.3 0.75
(0.17)
9.1 2,318 2,736 4,730
Abbreviations. ARIC: Atherosclerosis Risk in Communities Study; CAPS: Carotid Atherosclerosis Progression Study; CHS: Cardiovascular Health Study;
CIRCS: Circulatory Risk in Communities Study; EAS: Edinburgh Artery Study; FATE: The Fireﬁghters and Their Endothelium Study; Hoorn: The Hoorn
Study; KIHD: Kuopio Ischaemic Heart Disease Risk Factor Study; Malmö: Malmö Diet and Cancer Study, MESA; Multi-race/ethnic Study of
Atherosclerosis; NBS: Nijmegen Biomedical Study 2; NOMAS: Northern Manhattan Study; OSACA2: Osaka Follow-Up Study for Carotid Atherosclerosis
2; Tromsø: Tromsø Study; Whitehall: Whitehall II Study; CIMT: mean common carotid intima media thickness; FU: follow-up duration; MI: myocardial
infarction; USA: United States of America; UK: United Kingdom; NLD: The Netherlands.
doi:10.1371/journal.pone.0132321.t001
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years, with a total follow-up of 547,887 person years. During this time 4,730 CV events, i.e.,
fatal or non-fatal myocardial infarction or stroke, occurred.
Asians and Hispanics were older than Blacks and Whites (64 versus 58 years). While sex in
Whites was balanced, Blacks and Hispanics were mainly women (61% and 55%) and Asians
were predominantly male (65%). Blacks and Hispanics had notably higher BMIs and a higher
prevalence of diabetes mellitus as compared to Whites and Asians. Hispanics had lower rates
of smoking (13.8%) compared to Blacks (23.7%), while the prevalence of smoking in Whites
and Asians was comparable (respectively 19.6% and 21.3%). Mean LDL-cholesterol was highest
in Whites (3.8 mmol/L). In Asians and Hispanics mean LDL-cholesterol was 3.2 mmol/L, in
Blacks it was 3.4 mmol/L. Systolic blood pressure was 136 mmHg in Asians, 132 mmHg in His-
panics, 131 mmHg in Blacks and 130 mmHg in Whites. Baseline data for each race/ethnic
group are presented in Table 2.
Common CIMT
Mean common CIMT was 0.74 mm in Blacks, Whites and Hispanics and 0.78 mm in Asians.
The model with risk factors and interaction terms with ethnicity fitted the data better than
the model with risk factors alone (likelihood ratio test p<0.001). The interaction terms of eth-
nicity with age, HDL-cholesterol, smoking and systolic blood pressure were statistically signifi-
cant (p<0.05).
We thus found that for specific ethnicities risk factor associations were significantly differ-
ent fromWhites.
Table 2. Baseline properties per race/ethnic group.
Whites Blacks Asians Hispanics Total
Individuals (n) 46,788 7,200 3,816 2,407 60,211
Age, years 58.4 (10.1) 58.6 (9.9) 64.3 (7.3) 63.4 (10.0) 59.0 (10.0)
Gender, % men 52.4 39.3 64.5 44.5 51.3
CIMT, mm 0.74 (0.17) 0.74 (0.18) 0.78 (0.20) 0.74 (0.15) 0.75 (0.17)
Smoking, % yes 19.6 23.7 21.3 13.8 20.0
Diabetes, % yes 5.9 18.0 8.2 17.0 7.9
BMI, kg/m2 26.6 (4.4) 29.6 (6.0) 23.7 (3.3) 29.0 (5.0) 26.9 (4.8)
TC, mmol/L 5.8 (1.2) 5.4 (1.1) 5.3 (0.9) 5.2 (1.0) 5.7 (1.2)
HDL, mmol/L 1.4 (0.4) 1.4 (0.4) 1.4 (0.4) 1.2 (0.3) 1.4 (0.4)
LDL, mmol/L 3.8 (1.1) 3.4 (1.0) 3.2 (0.8) 3.2 (0.9) 3.7 (1.1)
TG, mmol/L 1.5 (1.0) 1.2 (0.8) 1.5 (0.9) 1.7 (1.0) 1.5 (0.9)
SBP, mmHg 130 (21) 131 (22) 136 (21) 132 (22) 131 (21)
DBP, mmHg 77 (12) 78 (12) 79 (12) 76 (12) 77 (12)
Stroke events (n) 1,732 398 125 63 2,318
MI events (n) 2,302 328 46 60 2,736
CV events (na) 3,780 665 168 117 4,730
Mean FU duration (years) 9.3 9.6 6.8 6.6 9.1
10-y event rateb 8.1 9.2 6.7 7.8 8.2
All data represent means (sd), unless stated otherwise.
a Number of individuals with a CV event (ﬁrst-time stroke or MI).
b10-year event rate, estimated using Kaplan-Meier analysis.
doi:10.1371/journal.pone.0132321.t002
Race/Ethnic Differences in Risk Factor Associations
PLOS ONE | DOI:10.1371/journal.pone.0132321 July 2, 2015 6 / 13
The magnitude of the association (i.e. betas of the linear regression model) of age with log-
CIMT was significantly smaller in Blacks and Hispanics as compared to Whites: 0.08/10 years
(91% of the White beta) and 0.09/10 years (97% of the White beta), respectively. This means
that every 10-year increase in age gives less increase in mean common CIMT in Blacks and
Hispanics than it does in Whites. The beta for HDL-cholesterol per 1 mmol/L increase was
-0.05 (144%) in Blacks (a stronger inverse association) as compared to the beta in Whites. The
beta for smoking (yes vs. no) was 0.01 (30% of the beta in Whites). In Asians the beta for SBP
was 0.02 (131% of the White beta). All betas are plotted in Fig 1 and are presented in Table 3.
CV events
The 10-year event rate was 6.7% in Asians, 7.8% in Hispanics, 8.1% in Whites and 9.2% in
Blacks.
The model including the risk factors and the interaction terms with ethnicity fitted the data
better than the model without interaction terms (likelihood ratio test p<0.001). Both age and
Fig 1. Association between risk factors andmean common CIMT, by ethnicity. Point estimates for
betas, lines represent 95% confidence intervals.
doi:10.1371/journal.pone.0132321.g001
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total cholesterol had a significant interaction with ethnicity. The HR for CV events (first-time
stroke or MI) per 10-year increase in age was lower in Blacks than in Whites (1.52 (1.44–1.60),
80% of the HR in Whites). The HR for a 1 mmol/L increase of total cholesterol was higher in
Blacks (1.20 (1.13–1.26), 140%) compared to Whites. The hazard ratios of the Framingham
risk factors per ethnic group are plotted in Fig 2.
Table 3. Effects of the Framingham risk factors in race/ethnic groups for the outcomes log CIMT (betas) and CV events (hazard ratios).
White Reference Black %
difference
Asian %
difference
Hispanic %
difference
IMT (betas, 95% CI)
Age 0.09 (0.09–
0.09)
100% 0.08 (0.08–
0.09)a
91% 0.09 (0.08–
0.10)
97% 0.08 (0.07–
0.09)a
90%
Diabetes 0.04 (0.04–
0.05)
100% 0.04 (0.03–0.05) 100% 0.07 (0.04–
0.09)
160% 0.03 (0.01–
0.05)
70%
BP drug use 0.02 (0.01–
0.02)
100% 0.01 (-0.00–
0.01)
38% 0.03 (0.01–
0.04)
166% 0.01 (-0.01–
0.03)
58%
Gender 0.04 (0.04–
0.05)
100% 0.05 (0.04–0.06) 118% 0.04 (0.02–
0.06)
93% 0.04 (0.03–
0.06)
100%
HDL −0.03 (−0.04−
−0.03)
100% −0.05 (−0.06−
−0.04)a
144% −0.04 (−0.06−
−0.02)
110% −0.02 (−0.04
−0.01)
48%
SBP 0.01 (0.01–
0.02)
100% 0.01 (0.01–0.02) 98% 0.02 (0.01–
0.02)a
131% 0.01 (0.01–
0.02)
91%
Smoking 0.03 (0.02–
0.03)
100% 0.01 (-0.00–
0.02)a
30% 0.05 (0.03–
0.08)
205% 0.02 (-0.00–
0.04)
66%
TC 0.01 (0.01–
0.01)
100% 0.02 (0.01–0.02) 140% 0.01 (-0.00–
0.02)
73% 0.01 (0.01–
0.02)
105%
CV eventsb (HRs,
95% CI)
Age 1.89 (1.86–
1.93)
100% 1.52 (1.44–
1.60)a
80% 1.75 (1.49–
2.01)
92% 1.69 (1.48–
1.90)
89%
Diabetes 1.95 (1.86–
2.05)
100% 2.13 (1.97–2.30) 109% 2.62 (2.20–
3.03)
134% 2.59 (2.20–
2.98)
133%
BP drug use 1.28 (1.21–
1.35)
100% 1.50 (1.34–1.66) 117% 1.47 (1.14–
1.79)
115% 0.93 (0.53–
1.32)
72%
Gender 1.52 (1.45–
1.59)
100% 1.35 (1.19–1.51) 89% 1.82 (1.42–
2.22)
119% 1.56 (1.17–
1.95)
102%
HDL 0.67 (0.58–
0.76)
100% 0.64 (0.44–0.85) 96% 0.88 (0.46–
1.29)
132% 0.91 (0.33–
1.49)
137%
SBP 1.15 (1.14–
1.17)
100% 1.18 (1.15–1.21) 103% 1.12 (1.05–
1.20)
98% 1.20 (1.12–
1.29)
104%
Smoking 1.96 (1.89–
2.04)
100% 1.70 (1.53–1.87) 87% 1.59 (1.25–
1.93)
81% 1.58 (1.09–
2.08)
81%
TC 1.09 (1.07–
1.12)
100% 1.20 (1.13–
1.26)a
110% 0.95 (0.78–
1.13)
87% 1.15 (0.96–
1.34)
105%
The top half of the table displays betas and 95% conﬁdence intervals of the Framingham risk factors for log CIMT for each race/ethnic group. The bottom
half of the table displays hazard ratios and 95% conﬁdence intervals of the Framingham risk factors for CV events for each race/ethnic group. The %
difference columns express the percentage difference in effect size (beta or hazard ratio) as compared to the White race/ethnic group. Risk factors printed
in bold have signiﬁcantly different effect sizes among race/ethnic groups (signiﬁcant interaction).
a Indicates signiﬁcant difference as compared to Whites (p<0.05)
b Cardiovascular events (ﬁrst-time stroke or MI).
doi:10.1371/journal.pone.0132321.t003
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Discussion
Our study shows that the associations of Framingham risk factors with subclinical atheroscle-
rosis and CV events have similar directions across race/ethnic groups. However, the magnitude
of the associations differs significantly for several risk factors among race/ethnic groups.
Prevalence of risk factors
The prevalence of risk factors in our cohort was unevenly distributed among the race/ethnic
groups (Table 2). Race/ethnic differences in the prevalence of CVD risk factors have been pre-
viously described. Similar to our study, smoking was least prevalent in Asians.[28] Also diabe-
tes was more prevalent in Blacks and Hispanics than in Asians andWhites[9], and the higher
prevalence of diabetes was accompanied with higher BMI in these groups.[29] Also in accor-
dance with literature, TC and LDL-cholesterol levels were highest in Whites, HDL-cholesterol
levels were lowest in Hispanics and triglyceride levels were lowest in Blacks.[30]
Fig 2. Association between risk factors and first-time stroke or myocardial infarction, by ethnicity.
Point estimates for hazard ratio’s, lines represent 95% confidence intervals.
doi:10.1371/journal.pone.0132321.g002
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However, in contrast with these similarities between our data and published literature,
blood pressure was highest in Asians, which is opposite to the findings in the Asia Pacific
cohort.[31] Possibly, this incongruence between our study and Asia Pacific can be explained by
differences in age, as the Asians in our cohort are older than the Whites (in the Asia Pacific
cohort the group from Australia and New Zealand is older than the Asians).
The observations made above indicate that our cohort is fairly similar to other cohorts
described in literature, thereby suggesting that our results might be generalizable.
CIMT and CVD—Differences and similarities
For Blacks, an increase in age was related to both an increase in mean common CIMT and a
higher risk of CV events, in our analyses. The magnitude of these associations, however, was
significantly smaller than in Whites. Although the direction of the association of age is the
same in Blacks as in Whites, an increasing age has less effect on disease in Blacks than in
Whites. This indicates that age is one of the factors that should be should weighted when devel-
oping a prediction model specifically for Blacks.
HDL-cholesterol and smoking in Blacks, SBP in Asians and age in Hispanics showed a dif-
ferent magnitude of the association with mean common CIMT as compared to Whites. How-
ever, these differences in the magnitude with mean common CIMT were not detected in the
analysis of CV events. This might be due to the difference in power between linear regression
and Cox proportional hazards analysis (which is driven by the number of events), or a differ-
ence in biology of CIMT and the actual occurrence of CV events.
The association between TC and CV event was significantly higher for Blacks as compared
to Whites. The coefficient for TC on mean common CIMT was also higher than the coefficient
in Whites, although this difference did not reach statistical significance.
When it comes to geographical differences, some of these differences have been reported
before. The Asia Pacific study reported lower HRs for triglycerides and SBP for respectively
coronary heart disease and hemorrhagic stroke, when comparing Asian countries with Austra-
lia and New-Zealand.[32] The INTERHEART study[33] showed in an analysis of 52 countries
across the globe that odds ratios for myocardial infarction were comparable, although (small)
differences in effect sizes exist. These geographical differences are in agreement with our race/
ethnicity-specific findings.
Race/ethnicity-specific risk prediction should be exercised with discretion. Unwanted medi-
cal “discrimination” that could be perceived by patients should be avoided at all costs. On the
other hand optimal risk estimation is of paramount importance for medical care. Adding race/
ethnicity to risk prediction equations thus should be implemented with care and reasons to do
so should be clarified to all parties, as to avoid undesirable situations in health care and society.
Limitations
Due to differences in ascertaining and recording ethnicity per cohort, misclassification might
have occurred and may have diluted our results to some extent. While we are aware of the
growing number of people from mixed backgrounds, people of mixed race/ethnicity were
excluded from the current analyses. Also, our Asian and Hispanic race/ethnic groups were rela-
tively small, which may have led to a lack of power. Therefore, our conclusions on these groups
should be interpreted with caution.
We were unable to take immigration status or acculturation into account, although time
since immigration has been shown to influence mean common CIMT, risk factors levels and
risk of cardiovascular events.[34,35] Therefore we cannot determine in which way immigration
status might influence our results, or whether the results are influenced at all.
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In our CV events analysis we were unable to take differences in prevention and treatment
strategies into account, these might differ among the ethnic groups and influence the occur-
rence of CV events.
Conclusion
In conclusion, the associations of the Framingham risk factors with atherosclerosis (CIMT)
and CVD had similar directions across race/ethnic groups. However, the magnitude of associa-
tions between risk factors and the presence of atherosclerotic disease differs between race/eth-
nic groups. These subtle, yet significant differences provide insight in the etiology of
cardiovascular disease among race/ethnic groups. These insights aid the race/ethnic-specific
implementation of primary prevention.
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